BANK VONTOBEL/CALL/CVS HEALTH/70/0.1/20.09.24 Share Price

Warrant

DE000VM3MA80

Delayed Deutsche Boerse AG 01:41:19 26/06/2024 pm IST
0.063 EUR -11.27% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/70/0.1/20.09.24
Current month+9.23%
1 month+86.84%
Date Price Change
26/24/26 0.063 -11.27%
25/24/25 0.071 -14.46%
24/24/24 0.083 +1.22%
21/24/21 0.082 -5.75%
20/24/20 0.087 -1.14%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 01:41 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM3MA8
ISINDE000VM3MA80
Date issued 06/10/2023
Strike 70 $
Maturity 20/09/2024 (87 Days)
Parity 10 : 1
Emission price 0.79
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.46
Lowest since issue 0.025
Spread 0.01
Spread %14.08%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.44 USD
Average target price
69.1 USD
Spread / Average Target
+14.32%
Consensus